2 01/07/2023 30/06/2024 2024-06-30 false false false false false false false true false false true false false false false false false false No description of principal activities is disclosed 2023-07-01 Sage Accounts Production 23.0 - FRS102_2023 xbrli:pure xbrli:shares iso4217:GBP 07531539 2023-07-01 2024-06-30 07531539 2024-06-30 07531539 2023-06-30 07531539 2022-07-01 2023-06-30 07531539 2023-06-30 07531539 2022-06-30 07531539 bus:RegisteredOffice 2023-07-01 2024-06-30 07531539 bus:LeadAgentIfApplicable 2023-07-01 2024-06-30 07531539 bus:Director1 2023-07-01 2024-06-30 07531539 bus:Director2 2023-07-01 2024-06-30 07531539 core:WithinOneYear 2024-06-30 07531539 core:WithinOneYear 2023-06-30 07531539 bus:Micro-entities 2023-07-01 2024-06-30 07531539 bus:AuditExemptWithAccountantsReport 2023-07-01 2024-06-30 07531539 bus:SmallCompaniesRegimeForAccounts 2023-07-01 2024-06-30 07531539 bus:PrivateLimitedCompanyLtd 2023-07-01 2024-06-30 07531539 bus:FullAccounts 2023-07-01 2024-06-30
Company registration number: 07531539
GG Khoury Oncology Limited
Unaudited filleted financial statements
30 June 2024
GG Khoury Oncology Limited
Contents
Directors and other information
Accountants report
Statement of financial position and notes to the financial statements
GG Khoury Oncology Limited
Directors and other information
Directors Dr G G Khoury
Mrs S Khoury
Company number 07531539
Registered office 28 Landport Terrace
Portsmouth
Hampshire
PO1 2RG
Accountants David Bailey Chartered Accountants
28 Landport Terrace
Portsmouth
Hampshire
PO1 2RG
GG Khoury Oncology Limited
Chartered accountants report to the board of directors on the preparation of the
unaudited statutory financial statements of GG Khoury Oncology Limited
Year ended 30 June 2024
In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of GG Khoury Oncology Limited for the year ended 30 June 2024 which comprise the statement of financial position and related notes from the company's accounting records and from information and explanations you have given us.
As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed at http://www.icaew.com /en/members/regulations-standards-and-guidance/.
This report is made solely to the board of directors of GG Khoury Oncology Limited, as a body, in accordance with the terms of our engagement letter dated 5 April 2018. Our work has been undertaken solely to prepare for your approval the financial statements of GG Khoury Oncology Limited and state those matters that we have agreed to state to the board of directors of GG Khoury Oncology Limited as a body, in this report in accordance with ICAEW Technical Release 07/16 AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than GG Khoury Oncology Limited and its board of directors as a body for our work or for this report.
It is your duty to ensure that GG Khoury Oncology Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of GG Khoury Oncology Limited. You consider that GG Khoury Oncology Limited is exempt from the statutory audit requirement for the year.
We have not been instructed to carry out an audit or a review of the financial statements of GG Khoury Oncology Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.
David Bailey Chartered Accountants
28 Landport Terrace
Portsmouth
Hampshire
PO1 2RG
24 March 2025
GG Khoury Oncology Limited
Statement of financial position
30 June 2024
2024 2023
£ £ £ £
Fixed assets 2,218 2,913
_______ _______
Current assets 70,355 164,205
Prepayments and accrued income 160 -
_______ _______
70,515 164,205
Creditors: amounts falling due within one year ( 13,801) ( 35,671)
_______ _______
Net current assets 56,714 128,534
_______ _______
Total assets less current liabilities 58,932 131,447
_______ _______
Net assets 58,932 131,447
_______ _______
Capital and reserves 58,932 131,447
_______ _______
Notes to the financial statements
GG Khoury Oncology Limited
Year ended 30 June 2024
1. Employee numbers
The average number of persons employed by the company during the year amounted to 2 (2023: 3 ).
For the year ending 30 June 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors responsiblities:
- The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
The financial statements have been prepared in accordance with the micro-entity provisions and have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.
These financial statements were approved by the board of directors and authorised for issue on 17 March 2025 , and are signed on behalf of the board by:
Dr G G Khoury Mrs S Khoury
Director Director
Company registration number: 07531539
The company is a private company limited by shares, registered in England & Wales.